Medical software QyScore®

hospitalimage analysisreporting

One scan at a time, QyScore® has the potential to revolutionize the treatment of CNS disease and create the potential for earlier precision on the frontlines of CNS disease. QyScore® is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. Our technology is a game changer. Powered by robust technology, our platform produces a wide range of automated measures of neuroinflammation and neurodegeneration, such as whole brain, white matter, grey matter by lobe, cerebellum, white matter abnormalities and brain substructures. To facilitate review by physicians, an automated patient report is rapidly generated after each QyScore® analysis and results are viewable in our proprietary and integrated 3D visualization platform. QyScore® decreases image reading variability and segmentation errors by 89% and has demonstrated better performance compared to certain other state-of-the-art automated methods on the market, promising precision and accuracy. Peace of mind for routine and research by providing results you can trust. QyScore® gives clinicians the potential to offer more accurate diagnosis and monitoring for patients, and the potential to bring enhanced trial design, improved patient selection, and endpoint protection to clinical trials. Our platform is cloud-based, easy to use and scales to fit your patient load or trial size.